Skip to main content
. 2019 Apr 2;7:e6683. doi: 10.7717/peerj.6683

Figure 2. Association with LncRNA MIR4435-2HG expression and clinicopathologic characteristics.

Figure 2

(A) T stage, (B) N stage, (C) M stage, (D) Clinical stage, (E) CEA levels before treatment. T, topography distribution; N, lymph node metastasis; M, distant metastasis.